Indications for Mechanical Thrombectomy for Acute Ischemic Stroke: Current Guidelines and Beyond

Area of Science:

• Neurology
• Interventional Cardiology
• Emergency Medicine

Background:

• Acute ischemic stroke management has rapidly evolved.
• Endovascular thrombectomy has emerged as a critical intervention for large vessel occlusion.
• Recent trials have redefined treatment windows and patient selection criteria.

Purpose of the Study:

• To review advancements in endovascular thrombectomy for acute ischemic stroke.
• To analyze the impact of thrombectomy on clinical guidelines.
• To discuss the implications of next-generation clinical trials.

Main Methods:

• Review of landmark randomized controlled trials (e.g., MR CLEAN, ESCAPE, DAWN, DEFUSE-3).
• Analysis of pooled data from collaborations (e.g., HERMES).
• Examination of emerging retrospective data and ongoing trials.

Main Results:

• Endovascular thrombectomy is superior to medical management for anterior circulation large vessel occlusion.
• Established efficacy in early windows (6-12 hours) and extended windows (up to 24 hours) in selected patients.
• Ongoing trials investigate thrombectomy for stroke patients with mild deficits or large infarct burden.

Conclusions:

• Endovascular thrombectomy is a highly effective treatment for specific acute ischemic stroke populations.
• Guidelines have been updated to reflect thrombectomy's benefits.
• Future research is crucial for expanding thrombectomy eligibility and optimizing patient outcomes.